Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 5.29% is 48% below its 5-year average of 10.26%, around the middle of its 5-year range (-20.21%–26.09%).
10.36% below its 12-month average of 5.90%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 2.45%.
NET PROFIT MARGIN
5.29%
NET PROFIT MARGIN AVG TTM
5.90%
NET PROFIT MARGIN AVG 3Y
5.70%
NET PROFIT MARGIN AVG 5Y
10.26%
NET PROFIT MARGIN AVG 10Y
12.53%
NET PROFIT MARGIN AVG 15Y
12.46%
NET PROFIT MARGIN AVG 20Y
10.02%
CURRENT VS TTM AVG
-10.36%
CURRENT VS 3Y AVG
-7.19%
CURRENT VS 5Y AVG
-48.45%
CURRENT VS 10Y AVG
-57.79%
CURRENT VS 15Y AVG
-57.55%
CURRENT VS 20Y AVG
-47.20%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+2134.62%
vs the sector median at left
Repligen Corporation
Market Cap
$10.04B
Net Profit Margin
5.29%
TTM Avg
5.90%
3Y Avg
5.70%
5Y Avg
10.26%
Market Cap
$10.06B
Net Profit Margin
6.90%
TTM Avg
6.89%
3Y Avg
6.71%
5Y Avg
6.89%
Market Cap
$9.98B
Net Profit Margin
8.59%
TTM Avg
-21.22%
3Y Avg
-48.94%
5Y Avg
16.61%
Market Cap
$10.18B
Net Profit Margin
9.99%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
Market Cap
$10.23B
Net Profit Margin
-0.02%
TTM Avg
1.97%
3Y Avg
2.41%
5Y Avg
2.58%
Market Cap
$10.32B
Net Profit Margin
-598.56%
TTM Avg
-1557.47%
3Y Avg
-67611.49%
5Y Avg
-57374.18%
Market Cap
$10.35B
Net Profit Margin
17.03%
TTM Avg
11.20%
3Y Avg
12.20%
5Y Avg
12.89%
Market Cap
$10.46B
Net Profit Margin
-12.18%
TTM Avg
-18.34%
3Y Avg
-27.51%
5Y Avg
-50.59%
Market Cap
$9.65B
Net Profit Margin
2.96%
TTM Avg
3.05%
3Y Avg
3.43%
5Y Avg
3.79%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Repligen Corporation (RGEN) | $10.04B | 5.29% | 5.90% | 5.70% | 10.26% |
| The Ensign Group, Inc. (ENSG)vs › | $10.06B | 6.90% | 6.89% | 6.71% | 6.89% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.98B | 8.59% | -21.22% | -48.94% | 16.61% |
| Align Technology, Inc. (ALGN)vs › | $10.18B | 9.99% | 10.36% | 10.48% | 22.21% |
| Molina Healthcare, Inc. (MOH)vs › | $10.23B | -0.02% | 1.97% | 2.41% | 2.58% |
| ImmunityBio, Inc. (IBRX)vs › | $10.32B | -598.56% | -1557.47% | -67611.49% | -57374.18% |
| Globus Medical, Inc. (GMED)vs › | $10.35B | 17.03% | 11.20% | 12.20% | 12.89% |
| 10x Genomics, Inc. (TXG)vs › | $10.46B | -12.18% | -18.34% | -27.51% | -50.59% |
| Henry Schein, Inc. (HSIC)vs › | $9.65B | 2.96% | 3.05% | 3.43% | 3.79% |
| Krystal Biotech, Inc. (KRYS)vs › | $9.62B | 54.82% | 41.66% | 26.22% | 17.48% |
Operating Margin
8.3%
Net Profit Margin
5.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 2.45% |
| 2026-03-31 | 4.29% |
| 2025-12-31 | 6.71% |
| 2025-09-30 | 7.90% |
| 2025-06-30 | 8.15% |
| 2025-03-31 | 3.45% |
| 2024-12-31 | -20.21% |
| 2024-09-30 | -0.42% |
| 2024-06-30 | 3.60% |
| 2024-03-31 | 2.15% |
| 2023-12-31 | -16.37% |
| 2023-09-30 | 11.99% |
| 2023-06-30 | 12.43% |
| 2023-03-31 | 9.27% |
| 2022-12-31 | 26.09% |
| 2022-09-30 | 20.13% |
| 2022-06-30 | 24.01% |
| 2022-03-31 | 22.75% |
| 2021-12-31 | 15.61% |
| 2021-09-30 | 18.80% |
| 2021-06-30 | 22.23% |
| 2021-03-31 | 20.62% |
| 2020-12-31 | 18.13% |
| 2020-09-30 | 15.47% |
| 2020-06-30 | 18.13% |
| 2020-03-31 | 12.90% |
| 2019-12-31 | 5.19% |
| 2019-09-30 | 2.39% |
| 2019-06-30 | 11.45% |
| 2019-03-31 | 13.28% |
| 2018-12-31 | 10.85% |
| 2018-09-30 | 9.68% |
| 2018-06-30 | 5.74% |
| 2018-03-31 | 7.69% |
| 2017-12-31 | 29.27% |
| 2017-09-30 | 12.76% |
| 2017-06-30 | 26.00% |
| 2017-03-31 | 10.03% |
| 2016-12-31 | 19.65% |
| 2016-09-30 | 4.68% |
| 2016-06-30 | 13.27% |
| 2016-03-31 | 6.48% |
| 2015-12-31 | 1.24% |
| 2015-09-30 | 12.81% |
| 2015-06-30 | 16.84% |
| 2015-03-31 | 14.07% |
| 2014-12-31 | -2.43% |
| 2014-09-30 | 9.60% |
| 2014-06-30 | 18.17% |
| 2014-03-31 | 26.20% |
| 2013-12-31 | 21.63% |
| 2013-09-30 | 31.28% |
| 2013-06-30 | 25.92% |
| 2013-03-31 | 14.21% |
| 2012-12-31 | 50.78% |
| 2012-09-30 | 11.96% |
| 2012-06-30 | 10.11% |
| 2012-03-31 | 9.56% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 7.01% |
| 2011-06-30 | -0.73% |
| 2011-03-31 | -34.38% |
| 2010-12-31 | 5.32% |
| 2010-09-30 | 8.53% |
| 2010-06-30 | 14.10% |
| 2010-03-31 | -33.44% |
| 2009-12-31 | -6.21% |
| 2009-09-30 | -18.07% |
| 2009-06-30 | -21.85% |
| 2009-03-31 | -58.63% |
| 2008-12-31 | 0.31% |
| 2008-09-30 | 2.79% |
| 2008-06-30 | 60.61% |
| 2008-03-31 | -96.87% |
| 2007-12-31 | -5.19% |
| 2007-09-30 | 753.06% |
| 2007-06-30 | 4.01% |
| 2007-03-31 | -2.89% |
| 2006-12-31 | -0.51% |
| 2006-09-30 | -30.14% |
| 2006-06-30 | 2.78% |
| 2006-03-31 | -28.41% |
| 2005-12-31 | -6.77% |
| 2005-09-30 | -16.70% |
| 2005-06-30 | 51.57% |
| 2005-03-31 | -14.25% |
| 2004-12-31 | -8.55% |
| 2004-09-30 | -132.57% |
| 2004-06-30 | -22.96% |
| 2004-03-31 | -154.05% |
| 2003-12-31 | -161.03% |
| 2003-09-30 | -150.83% |
| 2003-06-30 | -98.39% |
| 2003-03-31 | -82.89% |
| 2002-12-31 | -31.69% |
| 2002-09-30 | -64.16% |
